[1]
I. Kumar, “A review on pharmacokinetics, pharmacodynamics and clinical aspects of remdesivir and favipiravir for the treatment of coronavirus disease”, J. Drug Delivery Ther., vol. 11, no. 1, pp. 121–129, Jan. 2021, doi: 10.22270/jddt.v11i1.4475.